Here’s Why Vericel Corporation (VCEL) Shares Declined in the Second Quarter

Carillon Tower Advisers, an investment management company, released its “Carillon Scout Small Cap Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here. Economic slowdown, inflation, ongoing Russia-Ukraine war, and Federal Reserve actions provided uncertainty in the market. Investors reacted negatively to these issues; thus, the equity market declined considerably in the second quarter. The small-cap funds represented by the Russell 2000 Growth Index declined significantly in the quarter. Investing in small-cap companies involves more risk compared to other investments. In addition, you can check the top 5 holdings of the fund to know its best picks in 2022.

Carillon Tower Advisers discussed stocks like Vericel Corporation (NASDAQ:VCEL) in the second quarter 2022 investor letter. Headquartered in Cambridge, Massachusetts, Vericel Corporation (NASDAQ:VCEL) is a biopharmaceutical company. On October 6, 2022, Vericel Corporation (NASDAQ:VCEL) stock closed at $24.27 per share. One-month return of Vericel Corporation (NASDAQ:VCEL) was -6.73% and its shares lost 52.61% of their value over the last 52 weeks. Vericel Corporation (NASDAQ:VCEL) has a market capitalization of $1.164 billion.

Here is what Carillon Tower Advisers specifically said about Vericel Corporation (NASDAQ:VCEL) in its Q2 2022 investor letter:

Vericel Corporation (NASDAQ:VCEL) develops products for tissue replacement including the MACI cartilage and Epicel skin replacement products. The stock was down after management provided soft second-quarter guidance for the MACI product on the first-quarter earnings call.”

d13/Shutterstock.com

Vericel Corporation (NASDAQ:VCEL) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 11 hedge fund portfolios held Vericel Corporation (NASDAQ:VCEL) at the end of the second quarter which was 12 in the previous quarter.

We discussed Vericel Corporation (NASDAQ:VCEL) in another article and shared the list of small-cap stocks to buy according to Ken Fisher. In addition, please check out our hedge fund investor letters Q2 2022 page for more investor letters from hedge funds and other leading investors.

Suggested Articles:

Disclosure: None. This article is originally published at Insider Monkey.